HIKMA PHARMACEUTICALS PLC 23/04/2026 AGM
1Receive the Annual ReportAbstain
2Approve the Final Dividend of USD 48 Cents Per ShareFor
3Re-appoint PwC as the Auditors of the Company Oppose
4Allow the Audit Committee to Determine the Auditor's RemunerationFor
5Elect Khalid Nabilsi - Executive DirectorFor
6 Re-elect Victoria Hull - Chair (Non Executive)For
7Re-elect Said Darwazah - Chief ExecutiveFor
8Re-elect Mazen Darwazah - Vice Chair (Executive)Oppose
9Re-elect Douglas Hurt - Senior Independent DirectorFor
10Re-elect Ali Al-Husry - Non-Executive DirectorFor
11Re-elect Cynthia Flowers - Non-Executive DirectorFor
12Re-elect Laura Balan - Designated Non-ExecutiveFor
13Re-elect Deneen Vojta - Non-Executive DirectorAbstain
14Approve the Remuneration ReportFor
15Authorise Share RepurchaseFor
16Issue Shares with Pre-emption RightsFor
17Issue Shares for CashFor
18Issue Shares for Cash for the Purpose of Financing an Acquisition or Other Capital InvestmentFor
19Authorise Share RepurchaseFor
20Meeting Notification-related ProposalFor
21Approve the Rule 9 Waiver for the Share BuybackOppose
22Approve the Rule 9 Waiver for the 2027 Awards Oppose